SCHEMBL14927020

SCHEMBL14927020

Cc1cc2cc(-c3cccc(-c4ccccc4)c3)nc(CN=C(N)N)c2cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 3/20 0.41
▸ GRIN3B O60391 3/20 0.41
▸ GRIN1 Q05586 3/20 0.41
▸ GRIN2A Q12879 3/20 0.41
▸ GRIN2B Q13224 3/20 0.41
▸ GRIN2C Q14957 3/20 0.41
▸ GRIN3A Q8TCU5 3/20 0.41
▸ ASIC3 Q9UHC3 1/20 0.37
▸ HRH4 Q9H3N8 1/20 0.36
▸ PLAU P00749 3/20 0.33
▸ PLG P00747 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NPFFR1 Q9GZQ6 1/20 0.33
▸ NPFFR2 Q9Y5X5 1/20 0.33
▸ ATP4A P20648 3/20 0.33
▸ ATP4B P51164 3/20 0.33
▸ CTSA P10619 1/20 0.33
▸ PRSS1 P07477 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927016 0.89 ASIC1 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14927018 0.88 KIF11 (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14927019 0.85 CTSS (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL12070768 0.85 KDM4E (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14927107 0.82 MAPT (0.37) KDM4EALDH1A1MAPTCTSAESR1
SCHEMBL14927013 0.79 PLAU (0.49) ASIC3PLAUPLGKDM4EALDH1A1
SCHEMBL14927108 0.78 MAPKAPK2 (0.38) —
SCHEMBL14927071 0.77 CTSS (0.37) KDM4EALDH1A1MAPTATP4AATP4B
SCHEMBL16379005 0.77 NOS2 (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL12070767 0.76 KDM4E (0.49) KDM4EALDH1A1MAPTDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 GRIN2D 4609/4885GRIN3B 4088/4885GRIN1 2631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback